semaglutide vs retatrutide vs. Tirzepatide vs. Retatrutide: Which Weight Loss Treatme – NDA Medical Spa Retatrutide vs Tirzepatide vs Semaglutide

However, unlike FDA-approved drugs, they dont go through the agencys review process for safety, effectiveness or quality before reaching patients

Since the FDA approved Ozempic in 2017, the drugs manufacturer, Novo Nordisk, has not included warnings that the medication can cause gastroparesis in its prescription information

Heres what early studies have shown: Pancreatitis: Reported in about 0.4% Gallbladder problems: Seen in about 1.1% , with no cases in the placebo group Heart rhythm changes: Reported more often with retatrutide ( about 6% vs 3% with placebo ) Liver enzyme increases: Rare (around 1% ), with overall liver health markers staying stable While these serious side effects were uncommon, theyre still important to keep in mind

Reduced Fat Absorption: GLP-1 medications may limit the absorption of dietary fats, decreasing overall calorie intake from meals